<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://updates.zdnet.com/">
<channel>
	<title><![CDATA[cadila Resources | ZDNet]]></title>
	<link><![CDATA[http://updates.zdnet.com/tags/cadila.html]]></link>
	<description><![CDATA[White papers, case studies, technical articles, and blog posts relating to cadila]]></description>
	<s:counts start="0" returned="1" found="1" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Risks and potential in the polypill]]></title>
		<link><![CDATA[http://healthcare.zdnet.com/?p=2055]]></link>
		<description><![CDATA[The polypill revolution can mean enormous growth for the pharmacy regimen that has developed in the U.S. over the last 20 years, at a price much of the world can afford. The help it gives branded drug companies in extending patents is nothing compared to what it can do for...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 31 Mar 2009 08:52:22 -0700</pubDate>
		<category domain="http://updates.zdnet.com/tags/blood+pressure.html"><![CDATA[Blood Pressure]]></category>
		<category domain="http://updates.zdnet.com/tags/patent.html"><![CDATA[Patent]]></category>
		<category domain="http://updates.zdnet.com/tags/pill.html"><![CDATA[Pill]]></category>
		<category domain="http://updates.zdnet.com/tags/regimen.html"><![CDATA[Regimen]]></category>
		<category domain="http://updates.zdnet.com/tags/polypills.html"><![CDATA[Polypills]]></category>
		<category domain="http://updates.zdnet.com/tags/caduet.html"><![CDATA[Caduet]]></category>
		<category domain="http://updates.zdnet.com/tags/cadila.html"><![CDATA[Cadila]]></category>
		<category domain="http://updates.zdnet.com/tags/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://updates.zdnet.com/tags/dana+blankenhorn.html"><![CDATA[Dana Blankenhorn]]></category>
		<category domain="http://updates.zdnet.com/tags/dana+blankenhorn.html"><![CDATA[Dana Blankenhorn]]></category>
	</item>
</channel>
</rss>
